Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
Abstract Background The Australian Pancreatic Cancer Screening Program (APCSP) offers endoscopic ultrasound surveillance for individuals at increased risk of pancreatic ductal adenocarcinoma (PDAC) with all participants requiring assessment by a Familial Cancer Service before or after study enrolmen...
Main Authors: | Krithika Murali, Tanya M. Dwarte, Mehrdad Nikfarjam, Katherine M. Tucker, Rhys B. Vaughan, Marios Efthymiou, Allison Collins, Allan D. Spigelman, Lucinda Salmon, Amber L. Johns, David B. Williams, Martin B. Delatycki, Thomas John, Alina Stoita |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Hereditary Cancer in Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13053-021-00190-1 |
Similar Items
-
Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
by: Krithika Murali, et al.
Published: (2021-09-01) -
Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program
by: Tanya Dwarte, et al.
Published: (2019-10-01) -
Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
by: Carol Cremin, et al.
Published: (2020-06-01) -
The awareness of the citizens of Swietokrzyskie Voivodeship on the genetic predisposition on cancer
by: Izabela Kamila Wojarska
Published: (2017-01-01) -
Reactions to receiving family health information via infographic video
by: Aeilts, Amber
Published: (2019)